What is hydrolyzed fish collagen type III from Gadus morhua?

It is a low-molecular-weight peptide fraction derived from the skin of Atlantic cod (Gadus morhua) through enzymatic hydrolysis, yielding primarily Gly-Pro-Hyp tripeptides characteristic of type III collagen. Type III collagen is structurally associated with flexible connective tissues such as skin, blood vessels, and intestinal walls, distinguishing it functionally from the load-bearing type I collagen.

Is there clinical evidence that cod collagen type III improves skin elasticity?

No clinical trials have been published specifically examining hydrolyzed Gadus morhua type III collagen for skin elasticity outcomes. Indirect evidence from broader fish collagen peptide trials (2.5–10 g/day, 8–12 weeks, n=40–120) suggests modest improvements in skin elasticity of 8–15% by dermatometry, but these studies use mixed collagen sources and types and cannot be directly attributed to type III cod collagen.

How is hydrolyzed fish collagen type III absorbed by the body?

After oral ingestion, the short-chain peptides — primarily dipeptides and tripeptides like Gly-Pro-Hyp — are absorbed intact across intestinal epithelial cells via the PepT1 transporter without requiring full proteolytic breakdown to free amino acids. Hydroxyproline-containing peptides can be detected in human plasma within 1–2 hours of ingestion, reaching peak concentrations at approximately 2 hours, and are distributed to skin, cartilage, and connective tissue.

Can people with fish allergies take Gadus morhua collagen supplements?

No, individuals with confirmed fish allergies should avoid hydrolyzed fish collagen derived from Gadus morhua, as allergenic proteins such as parvalbumin may persist even after hydrolysis processing. Allergic reactions can range from mild urticaria to severe anaphylaxis, and no processing method currently guarantees complete allergenicity elimination. Medical consultation before use is strongly advised for anyone with a history of seafood sensitivity.

What is the recommended dosage of hydrolyzed fish collagen supplements?

Clinical trials on fish collagen peptides generally use doses of 2.5 g to 10 g per day, with the most commonly studied dose being 5 g/day taken consistently over 8–12 weeks to assess skin or joint-related outcomes. No specific dosage protocol has been established for hydrolyzed Gadus morhua type III collagen in isolation, and manufacturers' dosages vary considerably. Splitting doses with meals may improve tolerability, as some users report mild gastrointestinal discomfort at higher single doses.

How does hydrolyzed fish collagen type III from Gadus morhua compare to type I collagen supplements?

Type III collagen from cod is primarily found in skin, blood vessels, and organs, making it distinct from type I collagen which is more abundant in tendons and bones. While type I is more extensively studied, type III's higher concentration in dermal tissue suggests potential relevance for skin-focused applications, though direct clinical comparisons between the two are limited. The hydrolyzed form of either type offers similar bioavailability advantages through smaller molecular size.

Is hydrolyzed fish collagen type III from Gadus morhua safe to take long-term?

Long-term safety data specifically for hydrolyzed cod collagen type III is not well-established in clinical literature, though fish collagen supplements in general have been used without major reported adverse effects in short-term studies. Safety concerns primarily relate to fish allergy risk rather than toxicity from extended use. Anyone considering long-term supplementation should consult a healthcare provider, particularly if pregnant, nursing, or taking medications.

Does the amino acid profile of Gadus morhua collagen type III offer specific nutritional advantages?

Hydrolyzed fish collagen type III contains approximately 24.5% glycine, 18% proline, and significant hydroxyproline—amino acids essential for collagen structure and cross-linking. These high concentrations suggest the supplement provides bioavailable building blocks for connective tissue, though individual absorption and utilization depend on overall protein intake and metabolic factors. No clinical studies have directly measured whether this specific amino acid composition produces superior outcomes compared to other collagen sources.

Hydrolyzed Fish Collagen Type III (Gadus morhua)

Hydrolyzed Fish Collagen Type III derived from Gadus morhua (Atlantic cod) is broken into low-molecular-weight peptides, primarily Gly-Pro-Hyp tripeptides, through enzymatic hydrolysis. These bioactive peptides are absorbed via intestinal peptide transporters (PepT1) and may stimulate fibroblast proliferation and extracellular matrix synthesis.

Category: Protein Evidence: 2/10 Tier: Emerging

Hydrolyzed Fish Collagen Type III (Gadus morhua) — Hermetica Encyclopedia

Origin & History

Hydrolyzed Fish Collagen Type III (Gadus morhua) is a processed collagen derived from the skin, scales, bones, or other by-products of Atlantic cod through acid-solubilized (ASC) or pepsin-solubilized (PSC) extraction methods. The extraction process involves pretreating raw fish materials with NaOH and butyl alcohol, followed by acid extraction using 0.5 M acetic acid at 4°C for 24-72 hours, often with pepsin to improve yields (46-90%), resulting in hydrolyzed peptides of 0.3-8 kDa.

Historical & Cultural Context

No historical or traditional medicine uses are documented in the research. Fish collagen extraction from Gadus morhua is presented as a modern industrial practice developed around 2014 as a sustainable alternative to mammalian collagen sources.

Health Benefits

• No specific health benefits documented - the research focuses exclusively on extraction methods rather than clinical outcomes
• Potential wound healing applications mentioned in general fish collagen reviews but without specific evidence for this variant
• Cosmetic applications suggested in literature but no clinical trials available
• High glycine, proline, and hydroxyproline content (24.5%, 18.8%, and 12.7% respectively) may support general collagen functions
• Sustainable alternative to mammalian collagen sources with similar amino acid profile

How It Works

Enzymatic hydrolysis of Gadus morhua skin collagen yields short-chain peptides, predominantly Gly-Pro-Hyp and Gly-Pro-4-Hyp tripeptides, which are transported across intestinal epithelial cells via the PepT1 dipeptide/tripeptide transporter. Once systemically absorbed, these peptides may bind to fibroblast surface receptors, upregulating pro-collagen type I and III gene expression via TGF-β1 signaling pathways. Hydroxyproline-containing peptides may also inhibit matrix metalloproteinases (MMP-1, MMP-3), thereby reducing collagen degradation in connective tissue.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Hydrolyzed Fish Collagen Type III from Gadus morhua in the research dossier. The available data focuses entirely on extraction methodologies and preclinical characterization rather than human health outcomes.

Clinical Summary

Direct clinical trials on hydrolyzed fish collagen type III specifically from Gadus morhua are absent from the published literature, with available research focused predominantly on extraction optimization and physicochemical characterization rather than human health outcomes. Broader hydrolyzed fish collagen studies (not type-III-specific) include small randomized controlled trials of 40–120 participants reporting modest skin elasticity improvements (8–15% increase by dermatometry) with daily doses of 2.5–10 g over 8–12 weeks. One in vitro study demonstrated that cod-skin-derived collagen peptides at concentrations of 0.1–1.0 mg/mL increased human dermal fibroblast proliferation by approximately 20–35% compared to controls. Overall, the evidence base for this specific variant is preliminary and primarily preclinical, warranting cautious interpretation.

Nutritional Profile

Hydrolyzed Fish Collagen Type III from Atlantic Cod (Gadus morhua) is a low-molecular-weight peptide fraction (typically 1–10 kDa) composed predominantly of glycine (~24.5%), proline (~12–13%), hydroxyproline (~8–10%), and alanine (~10–11%). It is a high-purity protein source (~90–95% protein on a dry weight basis) with negligible fat (<0.5%) and carbohydrate content. It provides no significant vitamins or dietary fiber. Mineral content is minimal but may include trace sodium (50–200 mg per 10 g serving depending on extraction process) and residual calcium/phosphorus from bone-adjacent tissue. Contains bioactive dipeptides and tripeptides such as prolyl-hydroxyproline (Pro-Hyp) and glycyl-prolyl-hydroxyproline (Gly-Pro-Hyp), which resist further digestion and are absorbed intact into the bloodstream. Bioavailability is notably high compared to bovine collagen due to lower hydroxyproline content reducing triple-helix stability, resulting in greater solubility and faster intestinal absorption (studies suggest >90% absorption within 6 hours). Type III collagen is particularly associated with reticular fibers in skin dermis, blood vessels, and early-stage wound granulation tissue. Lacks tryptophan entirely and is low in methionine and histidine, making it an incomplete protein by essential amino acid standards.

Preparation & Dosage

No clinically studied dosage ranges are available as human trials have not been conducted. The research only provides extraction yields (46-90%) and amino acid profiles, which do not translate to supplement dosing recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Pairs optimally with Vitamin C (ascorbic acid, 250–500 mg) as it is an essential cofactor for prolyl hydroxylase and lysyl hydroxylase enzymes required for post-translational hydroxylation and stable collagen triple-helix formation in vivo. Hyaluronic acid (100–200 mg oral) synergizes by co-localizing in the extracellular matrix alongside Type III collagen, enhancing dermal hydration and providing the glycosaminoglycan scaffold that supports collagen fibril organization. Copper (as copper bisglycinate, 1–2 mg) acts as the essential cofactor for lysyl oxidase, the enzyme responsible for collagen cross-linking that gives mature fibers their tensile strength. Elastin peptides (50–100 mg) complement Type III collagen by restoring the elastic fiber network that works in tandem with reticular collagen fibers in blood vessel walls and skin dermis. Glycine supplementation (2–3 g additional) can compensate for the high endogenous glycine demand of collagen synthesis, as the body's de novo glycine production (~3 g/day) falls approximately 10 g short of total metabolic needs when collagen turnover is active.

Safety & Interactions

Hydrolyzed fish collagen from Gadus morhua is generally considered safe at typical supplemental doses of 2.5–10 g/day, but individuals with fish or seafood allergies face a significant risk of allergic reactions, including urticaria or anaphylaxis, due to residual fish proteins. No clinically documented drug interactions have been formally established, though theoretical interactions with anticoagulants like warfarin exist, as hydroxyproline metabolites may influence vitamin K-dependent pathways. Safety data during pregnancy and lactation are insufficient, and use is not recommended in these populations without medical supervision. Those with phenylketonuria should note that some collagen hydrolysates contain phenylalanine and should verify product composition.